Premium
KL1: SWOT analysis of currently available anti‐HCV therapies
Author(s) -
Foster G
Publication year - 2013
Publication title -
journal of viral hepatitis
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.329
H-Index - 100
eISSN - 1365-2893
pISSN - 1352-0504
DOI - 10.1111/jvh.12164
Subject(s) - telaprevir , boceprevir , ribavirin , tolerability , dosing , protease , medicine , pegylated interferon , pharmacology , protease inhibitor (pharmacology) , intensive care medicine , bioinformatics , virology , biology , hepatitis c virus , adverse effect , virus , viral load , biochemistry , antiretroviral therapy , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom